2026-05-17T05:19:21Zhttps://riubu.ubu.es/oai/request

oai:riubu.ubu.es:10259/87002024-02-20T01:05:23Zcom_10259_5645com_10259_5086com_10259_2604com_10259_4734com_10259_7906col_10259_5646col_10259_4735col_10259_8017

Sáiz Vázquez, Olalla Puente Martínez, Alicia Ubillos Landa, Silvia Pacheco Bonrostro, Joaquín Santabárbara, Javier 2024-02-19T11:36:03Z 2024-02-19T11:36:03Z 2020-06 http://hdl.handle.net/10259/8700 10.3390/brainsci10060386 2076-3425 Alzheimer’s disease (AD) is the most common subtype of dementia. In the last ten years, the relationship between cholesterol and AD has been investigated. Evidence suggests that cholesterol is associated with AD and represents promising targets for intervention. However, the causality of these associations is unclear. Therefore, we sought to conduct a meta-meta-analysis to determine the effect of cholesterol on the development AD. Then, we assessed the effect of serum levels of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC) and triglycerides (TG), on AD risk. eng http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess Atribución 4.0 Internacional Alzheimer's disease Etiology Cholesterol Risk factors Meta-analysis Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis info:eu-repo/semantics/article